monoclonal antibodies

Health & Safety

Federal Supply Deal For COVID-19 Antibody Treatment Lacks Some Customary Protections

2:19pm November 06, 2020

by Sydney Lupkin

To boost the supply of Regeneron's antibody therapy for COVID-19, the federal government entered into a $450 million supply contract. Details of the deal show some safeguards are missing.

An Eli Lilly researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis.

Health & Safety

Government Signs Deal For COVID-19 Treatments From Eli Lilly

5:35pm October 28, 2020

by Richard Harris

The federal government plans to distribute 300,000 doses of the drug at no cost, but that doesn't mean treatment will be free. Intravenous infusion charges can run more than $1,000.

Eli Lilly researchers prepare cells to produce possible COVID-19 antibodies in a laboratory in Indianapolis. The drugmaker has asked the U.S. government to allow emergency use of its experimental antibody therapy.

Health & Safety

How Will The Limited Supply Of Antibody Drugs For COVID-19 Be Allocated?

11:41pm October 21, 2020

by Richard Harris

Experimental medicines have the potential to help people with COVID-19 avoid hospitalization. The scarce supply of the treatments would have to be rationed, if regulators OK their use.

Queue Listen Now

An Eli Lilly researcher tests possible COVID-19 antibodies in a company laboratory in Indianapolis.

Health & Safety

Trump Touts Antibody Treatments For COVID-19, But Evidence Is Incomplete

11:04pm October 08, 2020

by Richard Harris

Medical researchers have high hopes that the kind of treatment the president received could end up being an important element in the fight against the pandemic. But clinical trials continue.

English coronavirus patients George Gilbert, 85, and his wife, Domneva Gilbert, 84, were part of a clinical trial that included Eli Lilly & Co.'s baricitinib.

Health & Safety

Experimental Medicines For COVID-19 Could Help Someday, But Home Runs Not Guaranteed

4:22pm September 18, 2020

by Richard Harris

Drugs are being tested that could reduce symptoms and save lives. But, given the way drugs are developed, it's unlikely that any single medicine will be anywhere as potent as a successful vaccine.

Queue Listen Now

A researcher at the German Center for Immunity Therapy holds a bag containing blood plasma from a recovered COVID-19 patient at the University Hospital Erlangen on April 27, 2020 in Erlangen, Germany. This plasma could be used to treat people with COVID-1

Five Coronavirus Treatments In Development

12:05pm June 11, 2020

by Joe Palca

While only remdesivir has been scientifically shown to help treat COVID-19, it is not a particularly effective drug. More drugs like it and fundamentally different ones are in the pipeline.

After testing positive for COVID-19, Diana Berrent established Survivor Corps, a grassroots clearinghouse for COVID-19 survivors interested in donating blood plasma to organizations developing therapies that might combat the disease.

Market For Blood Plasma From COVID-19 Survivors Heats Up

5:00am May 11, 2020

by JoNel Aleccia

As many firms and academic researchers vie for blood donations from survivors in hopes of isolating components for new treatments, one project is turning for help from 10,000 Orthodox Jewish women.

Regeneron Pharmaceuticals, headquartered near Tarrytown, N.Y., is just one of the companies now working to identify and reproduce large quantities of antibodies that could prevent or treat COVID-19. Senior R&D Specialist Kristen Pascal works on COVID-19 r

How Monoclonal Antibodies Might Prove Useful Against The Coronavirus

5:35pm March 26, 2020

by Joe Palca

A treatment strategy that identifies particularly potent immune system proteins, then gins up mass quantities for a single dose might help prevent infections or quell symptoms, scientists say.

Research & Development associate Divya Nagalati works on cell cultures in Regeneron's infectious disease labs in Tarrytown, N.Y. The firm is looking for tailored antibodies that might prove useful against the new coronavirus.

Hunt For New Coronavirus Treatments Includes Gene-Silencing And Monoclonal Antibodies

4:09pm February 19, 2020

by Joe Palca

The new coronavirus has spurred biotech labs in universities and companies to try to find new approaches to stopping the virus — from blocking its key enzymes to interfering with its genetics.

In this colorized image of a brain cell from a person with Alzheimer's, the red tangle in the yellow cell body is a toxic tangle of misfolded "tau" proteins, adjacent to the cell's green nucleus.

Alzheimer's Drugs In The Works Might Treat Other Diseases, Too

10:28am July 22, 2015

by Jon Hamilton

By targeting the process that creates toxic clumps of protein in brain cells, scientists hope to help not just Alzheimer's patients, but perhaps also people with Lewy body dementia and Parkinson's.

Queue Listen Now